MAO Inhibitors
- PMID: 32491327
- Bookshelf ID: NBK557395
MAO Inhibitors
Excerpt
Monoamine oxidase inhibitors (MAO Inhibitors) are medications used to manage and treat depression, among other neurological and psychiatric illnesses. It is in the Antidepressants class of drugs. This activity reviews the indications, action, and contraindications of the commonly prescribed MAO Inhibitors as a valuable agent in managing depression and other neuropsychiatric disorders. This activity will highlight the mechanism of action, adverse event profile, and other key factors such as off-label use, administration, and relevant molecular interactions pertinent for the interprofessional team members involved in the care of patients with depression and related conditions.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
Similar articles
-
Responsible Controlled Substance and Opioid Prescribing.2024 Dec 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Dec 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 34283451 Free Books & Documents.
-
Gadolinium Magnetic Resonance Imaging.2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 29494094 Free Books & Documents.
-
West Virginia Opioid Prescribing for Chronic Pain While Avoiding Drug Diversion.2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 33090753 Free Books & Documents.
-
Systematic review of depression in patients with multiple sclerosis and its relationship to interferonβ treatment.Mult Scler Relat Disord. 2017 Oct;17:138-143. doi: 10.1016/j.msard.2017.07.008. Epub 2017 Jul 12. Mult Scler Relat Disord. 2017. PMID: 29055445 Review.
-
A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke.Neurotoxicology. 2022 Dec;93:163-172. doi: 10.1016/j.neuro.2022.09.008. Epub 2022 Sep 23. Neurotoxicology. 2022. PMID: 36155069 Review.
References
-
- López-Muñoz F, Alamo C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des. 2009;15(14):1563-86. - PubMed
-
- Menkes D, Bosanac P, Castle D. MAOIs - does the evidence warrant their resurrection? Australas Psychiatry. 2016 Aug;24(4):371-3. - PubMed
-
- Stein DJ, Ipser JC, Balkom AJ. Pharmacotherapy for social phobia. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001206. - PubMed
-
- Nelson JC, Spyker DA. Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000-2014. Am J Psychiatry. 2017 May 01;174(5):438-450. - PubMed
-
- Thase ME. The role of monoamine oxidase inhibitors in depression treatment guidelines. J Clin Psychiatry. 2012;73 Suppl 1:10-6. - PubMed
Publication types
LinkOut - more resources
Full Text Sources